Chemical Structure : BBT-176
Catalog No.: PC-23647Not For Human Use, Lab Use Only.
BBT-176 is a potent, mutant-selective fourth-generation inhibitor of EGFR C797S mutations with IC50 of 4.36, 1.79, and 5.35 nM for EGFR 19Del/C797S, EGFR 19Del/T790M/C797S, and EGFR L858R/C797S, respectively.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
BBT-176 is a potent, mutant-selective fourth-generation inhibitor of EGFR C797S mutations with IC50 of 4.36, 1.79, and 5.35 nM for EGFR 19Del/C797S, EGFR 19Del/T790M/C797S, and EGFR L858R/C797S, respectively.
BBT-176 selectively and noncovalently inhibits triple-mutant EGFR 19Del/T790M/C797S and L858R/T790M/C797S at nanomolar concentrations.
BBT-176 has IC50 of 42, 49, 183, and 202 nM against Ba/F3 cells expressing EGFR 19Del/C797S, EGFR 19Del/T790M/C797S, EGFR L858R/C797S, and EGFR L858R/T790M/C797S, respectively.
BBT-176 strongly inhibited the tumor growth, and in some conditions induced tumor regression in mouse models.
M.Wt | 587.14 | |
Formula | C27H35ClN8O3S | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
1. Lim SM, et al. Clin Cancer Res. 2023 Aug 15;29(16):3004-3016.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright